354 related articles for article (PubMed ID: 29601122)
1. Oncologic outcomes of surgical treatment for T3 glottic laryngeal squamous cell carcinoma.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Head Neck; 2018 Aug; 40(8):1734-1742. PubMed ID: 29601122
[TBL] [Abstract][Full Text] [Related]
2. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Acta Otolaryngol; 2018 Nov; 138(11):1028-1034. PubMed ID: 30735065
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
4. [Selection of surgical modalities for T3 glottic carcinoma].
Wen SX; Wang BQ; Liu T; Huangfu H; Zhang HL; Zhang CM; Gao W; Feng Y
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):860-3. PubMed ID: 22335954
[TBL] [Abstract][Full Text] [Related]
5. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
6. [Treatment and prognosis of stage T3 glottic laryngeal cancer--a report of 65 cases].
Yu WB; Zeng ZY; Chen FJ; Peng HW
Ai Zheng; 2006 Jan; 25(1):85-7. PubMed ID: 16405757
[TBL] [Abstract][Full Text] [Related]
7. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
[TBL] [Abstract][Full Text] [Related]
8. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes of supracricoid partial laryngectomy with cricohyoidoepiglottopexy for glottic carcinoma.
Gong H; Zhou L; Wu H; Tao L; Chen X; Li X; Li C; Zhou J
Acta Otolaryngol; 2019 Sep; 139(9):803-809. PubMed ID: 31240973
[No Abstract] [Full Text] [Related]
10. [Treatment and prognosis of stage IV glottic laryngeal cancer].
Lai FY; Zhang Q; Guo ZM; Zeng ZY; Li H; Yu WB; Yang CS
Ai Zheng; 2008 Jan; 27(1):71-4. PubMed ID: 18184468
[TBL] [Abstract][Full Text] [Related]
11. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
12. [A clinical study of 213 patients with laryngeal cancer].
Miyahara H; Yane K; Tsuruta Y; Uemura H
Nihon Jibiinkoka Gakkai Kaiho; 2002 Jul; 105(7):790-8. PubMed ID: 12174612
[TBL] [Abstract][Full Text] [Related]
13. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients.
Canis M; Martin A; Ihler F; Wolff HA; Kron M; Matthias C; Steiner W
Head Neck; 2014 Jun; 36(6):859-66. PubMed ID: 23720321
[TBL] [Abstract][Full Text] [Related]
14. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
Peretti G; Piazza C; Penco S; Santori G; Del Bon F; Garofolo S; Paderno A; Guastini L; Nicolai P
Head Neck; 2016 Jul; 38(7):1107-12. PubMed ID: 26970262
[TBL] [Abstract][Full Text] [Related]
15. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
16. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
[TBL] [Abstract][Full Text] [Related]
17. Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx.
Gorphe P; Blanchard P; Breuskin I; Temam S; Tao Y; Janot F
J Laryngol Otol; 2015 Sep; 129(9):903-9. PubMed ID: 26201253
[TBL] [Abstract][Full Text] [Related]
18. Supracricoid partial laryngectomy in the management of t3 laryngeal cancer.
Mercante G; Grammatica A; Battaglia P; Cristalli G; Pellini R; Spriano G
Otolaryngol Head Neck Surg; 2013 Nov; 149(5):714-20. PubMed ID: 23921496
[TBL] [Abstract][Full Text] [Related]
19. [Long-term efficacy of supracricoid partial laryngectomy for 298 patients with laryngeal carcinoma].
Tao L; Zhou L; Wu HT; Gong HL; Chen XL; Li XM; Li C; Zhou J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):97-104. PubMed ID: 29429178
[No Abstract] [Full Text] [Related]
20. Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy.
Zhou J; Heng Y; Yang Y; Zhu X; Zhou L; Gong H; Xu C; Tao L
Oncol Lett; 2022 Dec; 24(6):434. PubMed ID: 36311684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
